You are here


ABL selected as preferred partner with Quanterix


ABL Lyon, a majority owned subsidiary of ABL, Inc., is a preferred partner with Quanterix Corporation, providing new ultrasensitive assays using single molecule measurement digital platform, Simoa. Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, has selected ABL, the first CRO in Europe with the ability to develop new assays and validate methods for research or clinical testing to detect femtomolar levels of analytes in preclinical or clinical samples.

ABL, Inc. Acquires Majority Interest in Platine Pharma Services


Rockville, MD, USA. ABL, Inc. (ABL), a biomedical contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the acquisition of a majority interest in Platine Pharma Services (Platine), a specialist in immunomonitoring and immunogenicity services. With laboratories located in Lyon, France, Platine helps clients in the biopharmaceutical, food, cosmetic and diagnostic industries evaluate the immunogenicity, activity and efficacy of products during R&D, preclinical and human clinical studies.

ABL and Indicia Biotechnology join forces to strengthen leadership in immuno-assays

  • ABL acquires the Assay Development activities of Indicia Biotechnology
  • With this transaction, ABL gets access to Indicia’s Immunoline™ proprietary platform and strengthens its position as a leader in immunomonitoring
  • Indicia Biotechnology becomes one of the major shareholders of ABL

Meet our team next month in Mainz, Germany


Our team will be happy to see you next month at Europe's largest meeting focued on cancer immunotherapy reasearch & development. A great opportunity to discuss your current and future needs in immunomonitoring! Don't hesitate to contact us at should you want to shedule a meeting in advance.

ABL Runs in Lyon


ABL was proud to be represented by Audrey and Claire as they ran the Alptis Challenge in Lyon on Sunday 7 October 2012.

ABL traveled to Glasgow for the ECI 2012


The European Congress of Immunology took place recently in Glasgow, Scotland.
It was the occasion for ABL's delegates to attend many high level Symposia and Workshops dedicated to the latest scientific breakthroughs in the field of Immunology, including recent findings in biomarker research, tumor immunology or advances in biologics.

ABL certified ISO 9001:2008


ABL, a specialist in immunomonitoring studies, today announced that its facilities and management system have received ISO (International Standards Organization) 9001:2008 certification